Can mupirocin ointment be used to treat a pressure ulcer (bedsore)?

Mupirocin Ointment for Bedsores (Pressure Ulcers)

Mupirocin ointment is not recommended as a standard treatment for pressure ulcers (bedsores). The highest-quality clinical practice guidelines do not include mupirocin among evidence-based interventions for pressure ulcer management, and systematic reviews show no clear benefit of topical antimicrobials, including antibiotics like mupirocin, for promoting pressure ulcer healing.

Evidence-Based Treatment Recommendations

The 2015 American College of Physicians (ACP) clinical practice guideline for pressure ulcer treatment provides clear recommendations based on systematic evidence review 1:

Recommended Interventions:

• Protein or amino acid supplementation to reduce wound size (weak recommendation, low-quality evidence)
• Hydrocolloid or foam dressings to reduce wound size (weak recommendation, low-quality evidence)
• Electrical stimulation as adjunctive therapy to accelerate wound healing (weak recommendation, moderate-quality evidence)

Notably absent from these guidelines is any recommendation for topical antibiotics like mupirocin for routine pressure ulcer treatment 1.

Why Mupirocin Is Not Appropriate for Routine Pressure Ulcer Care

Limited Evidence for Antimicrobials in Pressure Ulcers

A comprehensive Cochrane systematic review examining antibiotics and antiseptics for pressure ulcers found 2:

• No trials evaluated mupirocin specifically for pressure ulcers
• No clear evidence that topical antimicrobials improve pressure ulcer healing compared to non-antimicrobial treatments
• In some comparisons, non-antimicrobial treatments actually performed better
• Evidence quality ranged from moderate to very low

FDA-Approved Indications

The FDA label for mupirocin specifies its approved uses 3:

• Impetigo (superficial skin infections)
• Secondary infected traumatic skin lesions
• Nasal MRSA decolonization (specific formulation)

Pressure ulcers are not an FDA-approved indication for mupirocin 3.

Important Safety Considerations

The FDA label highlights critical warnings for mupirocin use 3:

• Polyethylene glycol base can be absorbed from open wounds and is renally excreted
• Should not be used when absorption of large quantities of polyethylene glycol is possible, especially with moderate or severe renal impairment
• Not formulated for use on mucosal surfaces
• Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi

These concerns are particularly relevant for pressure ulcers, which are often large, open wounds in patients with multiple comorbidities including renal impairment.

When Antimicrobials May Be Considered

Specific Clinical Scenarios

Topical antimicrobials (though not specifically mupirocin) might be considered only in pressure ulcers with 4:

• Clinical signs of infection (purulence, erythema, warmth, systemic signs)
• Positive cultures from wound aspirates or biopsies
• Immunocompromised patients with evidence of infection

Even in these scenarios, the IDSA guidelines for skin and soft tissue infections recommend 4:

• Intranasal mupirocin is reserved for MRSA decolonization in recurrent infections (5-day regimen twice daily)
• Systemic antibiotics are preferred for infected wounds with systemic signs
• Topical antibiotics are not first-line for most infected wounds

Recommended Approach for Pressure Ulcers

Standard Care Algorithm:

1. Address underlying causes:

   • Pressure relief with appropriate support surfaces
   • Nutritional optimization (protein/amino acid supplementation)
   • Management of comorbidities

2. Local wound care:

   • Use hydrocolloid or foam dressings (evidence-based)
   • Maintain moist wound environment
   • Consider electrical stimulation as adjunctive therapy

3. Reserve antimicrobials for:

   • Documented infection only (not colonization)
   • Prefer systemic antibiotics for infected pressure ulcers with systemic signs
   • Culture-directed therapy when possible

4. Avoid routine topical antibiotics:

   • No evidence of benefit for healing
   • Risk of resistance development
   • Potential for adverse effects (especially with polyethylene glycol base in renal impairment)

Common Pitfalls to Avoid

• Do not use mupirocin prophylactically on uninfected pressure ulcers—this promotes antibiotic resistance without proven benefit 2, 5
• Do not confuse colonization with infection—pressure ulcers are commonly colonized with bacteria, but this does not require antibiotic treatment
• Be cautious in patients with renal impairment—the polyethylene glycol vehicle in mupirocin ointment poses specific risks in this population 3
• Do not use mupirocin as a substitute for evidence-based interventions—focus on pressure relief, nutrition, and appropriate dressings 1

Bottom Line

Focus treatment on the evidence-based triad: protein supplementation, hydrocolloid/foam dressings, and electrical stimulation 1. Reserve any antimicrobial therapy, including mupirocin, for documented infections only, and recognize that mupirocin specifically lacks evidence for pressure ulcer treatment and carries safety concerns in this population 3, 2.